HLB Co., Ltd. HLB Co., Ltd.

HLB Co., Ltd.

028300

株式のランク #4140
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
株価
$29.28
時価総額
$3.89B
変化(1日)
-1.40%
変化(1年)
-8.45%
国
KR
取引 HLB Co., Ltd. (028300)

カテゴリー

Healthcare
HLB Co., Ltd.(028300)の株式分割履歴
HLB Co., Ltd.株(シンボル:028300)は合計で9回の株式分割を実施しました。
最新の株式分割はAug 02, 2023に行われました。
Jun 01, 2005より前に購入された028300株は、現在0.028990089039949028300株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2023-08-02 21:20 x1.05 x0.028990089039949
2022-12-28 521:500 x1.042 x0.027609608609475
2022-10-13 129:125 x1.032 x0.026496745306598
2021-03-15 2:1 x2 x0.025675140800967
2020-06-05 11:10 x1.1 x0.012837570400484
2020-04-17 513:500 x1.026 x0.011670518545894
2010-12-10 125000:2294551 x0.054476888942543 x0.011374774411203
2005-07-28 261:250 x1.044 x0.2088
2005-06-01 1:5 x0.2 x0.2
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH